期刊文献+

血清CA125和可溶性CD44标准型联合检测在恶性上皮性卵巢肿瘤诊断中的意义 预览

Significace of serum soluble sCD44std and CA125 in diagnosis of epithelial ovarian tumor
在线阅读 下载PDF
收藏 分享 导出
摘要 目的研究联合检测血清可溶性CD44标准型(sCD44std)和CA125在恶性上皮性卵巢肿瘤诊断中的临床意义。方法采用定量酶联免疫吸附试验(ELISA)检测恶性上皮性卵巢肿瘤患者(49例)、良性上皮性卵巢肿瘤患者(34例)和正常妇女(80例)血清的sCD44std和CA125水平。结果恶性上皮性卵巢肿瘤患者的sCD44std水平显著高于良性上皮性卵巢肿瘤患者和正常对照组(P〈0.05),良性上皮性卵巢肿瘤组患者与正常对照组的差异无显著性(P〉0.05)。不同类型的恶性上皮性卵巢肿瘤sCD44std的差异无显著性(P〉0.05)。sCD44std和CA125联合检测对恶性上皮性卵巢肿瘤诊断的灵敏度和正确率明显高于单项检测CA125或sCD44std(P值均〈0.05)。国际妇产科联盟(FIGO)分期Ⅰ/Ⅱ期恶性上皮性卵巢肿瘤的血清sCD44std灵敏度高于CA125,但差异无显著性(P〉0.05)。结论血清sCD44std和CA125联合检测可能提高恶性上皮性卵巢肿瘤的早期诊断率。 Objective To determine the serum sCD44std and CA125 in the diagnosis of malignant epithelial ovarian tumor and analyze their clinical significances. Methods The level of serum sCD44std and and CA125 were measured by ELISA including epithelial ovarian malignant tumor (n= 49), epithelial ovarian benign tumor (n=34), normal ovarian tissues (n= 80). Results ① Level of serum sCD44std: epithelial malignant tumor group was higher than that of the other two groups (P〈0.05), there was no significant difference between the other two groups (P〉0.05), also there was no significant difference among the different kinds of epithelial ovarian malignant tumor(P〉0.05) . ② Sensitivity and accuracy for the combination of of serum sCD44std and CA125 in epithelial ovarian malignant tumor : the sensitivity and accuracy were higher than those of CA125 alone(P〈0.05), or sCD44std alone ( P 〈 0.05). ③ Sensitivity of epithelial ovarian malignant tumor ( stage Ⅰ/ Ⅱ ) : sCD44std was higher than CA125, but there was no significant difference between the two groups(P〉0.05). Conclusions The level of serum sCD44std together with CA125 can promote the diagnosis of malignant epithelial ovarian tumor. (Shanghai Med J, 2006, 29..95-97)
作者 徐军 王红琳 林晓 陆杲川 孙蕾 石礼红 XU Jun, WANG Honglin, LIN Xiao, LU Gaochuan, SUN Lei, SHI Lihong(Department of Gynecology and Obstetrics, Shanghai Eighth People's Hospital ,Shanghai 200233, China)
出处 《上海医学》 CAS CSCD 北大核心 2006年第2期 95-97,共3页 Shanghai Medical Journal
基金 上海市卫生局科研基金资助项目(00403)
关键词 卵巢上皮性肿瘤 血清 可溶性CD44标准型 CA125 Epithelial ovarian tumour Serum Soluble CD44 standard CA125
  • 相关文献

参考文献7

  • 1Stirling D,Evans DG,Pichert G,et al.Screening for familial ovarian cancer:failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.J Clin Oncol,2005,23:5588-5596. 被引量:1
  • 2Jacobs I.Screening for familial ovarian cancer:the need for well-designed prospective studies.J Clin Oncol,2005,23:5443-5445. 被引量:1
  • 3Bourguignon LY,Gilad E,Rotbman K,et al.HyaluronanCD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling,leading to actin binding,Elk-1/estrogen receptor transcriptional activation,and ovarian cancer progression.J Biol Chem,2005,280:11961-11972. 被引量:1
  • 4Rodriguez-Rodriguez L,Sancho-Torres I,Mesonero C,et al.The CD44 receptor is a molecular predictor of survival in ovarian cancer.Med Oncol,2003,20:255-263. 被引量:1
  • 5Zeimet AG,Widschwendter M,Uhl-Steidl M,et al.High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.Br J Cancer,1997,76:1646-1651. 被引量:1
  • 6Nagano O,Saya H.Mechanism and biological significance of CD44 cleavage.Cancer Sci,2004,95:930-935. 被引量:1
  • 7Hofmann M,Rudy W,Gunthert U,et al.A link between ras and metastatic behavior of tumor cells:ras induces CD44 promoter activity and leads to low-level expression of metastasisspecific variants of CD44 in CREF cells.Cancer Res,1993,53:1516-1521. 被引量:1
投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈
新型冠状病毒肺炎防控与诊疗专栏